Synpromics Ltd. has entered a research collaboration with GE Healthcare to jointly develop customized synthetic promoters optimized for GE Healthcare’s biopharmaceutical manufacturing platform.   Synpromics will develop a bar-coded library of synthetic promoters using its PromPT platform for extensive screening in GE’s Chinese Hamster Ovary (CHO) – based expression system. The resulting characterized promoter toolbox may have broad applicability for increasing the yield of a range of bio...